VC-backed LogicBio expands leadership team
Cambridge, Massachusetts-based LogicBio Therapeutics, a genome editing company, has expanded its leadership team with four new appointments: Matthias Jaffe is now chief financial officer; Tom Wilton has become chief business officer; Nelson Chau is now vice president of biology; and Kelly Blackburn is clinical and regulatory strategist. LogicBio's backers include Arix Bioscience, OrbiMed, Edmond De Rothschild Investment Partners, Pontifax, SBI and OrbiMed Israel Partners.
2 January 2018•3 mins read
